<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The impact of <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> with HIV on the risk of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in children is uncertain, particularly for those living in sub-Saharan Africa </plain></SENT>
<SENT sid="1" pm="."><plain>In an ongoing study in a paediatric <z:hpo ids='HP_0002664'>oncology</z:hpo> centre in Malawi, children (aged &lt;/= 15 years) with known or suspected <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> are being recruited and tested for HIV and their mothers or carers interviewed </plain></SENT>
<SENT sid="2" pm="."><plain>This study reports findings for children recruited between 2005 and 2008 </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Only children with a <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> diagnosis were included </plain></SENT>
<SENT sid="4" pm="."><plain>Odds ratios (OR) for being HIV positive were estimated for each <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> type (with adjustment for age (&lt;5 years, &gt;/= 5 years) and sex) using children with other <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> and non-malignant conditions as a comparison group (excluding the known HIV-associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, Kaposi <z:hpo ids='HP_0100242'>sarcoma</z:hpo> and <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, as well as children with other <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">haematological malignancies</z:e> or with confirmed non-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> diagnoses) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Of the 586 children recruited, 541 (92%) met the inclusion criteria and 525 (97%) were tested for HIV </plain></SENT>
<SENT sid="6" pm="."><plain>Overall HIV seroprevalence was 10% </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">Infection</z:e> with HIV was associated with Kaposi <z:hpo ids='HP_0100242'>sarcoma</z:hpo> (29 cases; OR = 93.5, 95% CI 26.9 to 324.4) and with non-Burkitt, non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (33 cases; OR = 4.4, 95% CI 1.1 to 17.9) but not with Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (269 cases; OR = 2.2, 95% CI 0.8 to 6.4) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: In this study, only Kaposi <z:hpo ids='HP_0100242'>sarcoma</z:hpo> and non-Burkitt, non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> were associated with <z:e sem="disease" ids="C0019693" disease_type="Disease or Syndrome" abbrv="">HIV infection</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>The endemic form of Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, which is relatively frequent in Malawi, was not significantly associated with HIV </plain></SENT>
<SENT sid="10" pm="."><plain>While the relatively small numbers of children with other <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, together with possible limitations of diagnostic testing may limit our conclusions, the findings may suggest differences in the pathogenesis of HIV-related <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> in different parts of the world </plain></SENT>
</text></document>